HEALTHCARE, SCIENCE & LEARNING HealthcareTechnology Company Enabling Connected Care SPEAKER PROFILE KEY COMPANY FACTS • Dan Vahdat is Founder & CEO of Medopad, a British Key Corporate Facts Key Operating KPIs healthcare technology company enabling connected Headquarters London, UK Project growth 10x + care. • In 2018 Dan joined UK Prime Minister Theresa May on Founded 2011 Team growth 730% the China Trade Visit, meeting President Xi and Premier Li and announcing a number of major Employees 100-1000 Partnerships Apple & Tencent partnerships with Tencent and Ping An. • Dan studied Engineering and Mathematics, after Active Markets Global Acquisitions Sherbit (San Francisco - 2018) which he pursued his PhD in Bio-Engineering at Johns - LinkedIn’s 2018 Top Dan Vahdat Hopkins and Oxford University. Before finishing his Ownership Private – VCs Selected awards Startups List degree, he left to focus on Medopad. - UK Innovation is Great Award Funding $35m+ Founder & CEO Key Investors NWS Holdings, Bayer Leaps, Bupa Website medopad.com COMPANY PROFILE MEDOPAD @ NOAH Doing Business @ NOAH Main Presentation Topics • Medopad was recently named a $1 billion health tech company in the making by KPMG Present your business proposal through Healthcare Panel with • Medopad’s vision is to create a world where people can live longer. A world NOAH Connect app where the best minds continue doing their best work. A world where we can spend more time with our loved ones • The Medopad app takes a modular approach to remote patient monitoring which means it covers a wide variety of disease areas to deliver better and more personalised care by transforming the way patients and data interact with clinicians Attendees @NOAH • Medopad partners closely with the world’s largest healthcare systems, pharma Dan Vahdat, Founder & CEO companies, research institutes, insurers and technology companies like Apple and Tencent to solve some of the biggest problems in rare, chronic and complex disease monitoring. Most recently Medopad and Tencent co-developed an AI solution that can quantify disease progression in People with Parkinson’s 80